Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples